Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Provider experiences with relaxing restrictions on take-home medications for opioid use disorder during the COVID-19 pandemic: A qualitative systematic review.
Adams A, Blawatt S, MacDonald S, Finnick R, Lajeunesse J, Harrison S, Byres D, Schechter MT, Oviedo-Joekes E. Adams A, et al. Among authors: lajeunesse j. Int J Drug Policy. 2023 Jul;117:104058. doi: 10.1016/j.drugpo.2023.104058. Epub 2023 May 8. Int J Drug Policy. 2023. PMID: 37182352 Free PMC article. Review.
Clients' experiences on North America's first take-home injectable opioid agonist treatment (iOAT) program: a qualitative study.
Oviedo-Joekes E, Dobischok S, Carvajal J, MacDonald S, McDermid C, Klakowicz P, Harrison S, LaJeunesse J, Chow N, Brown M, Gill S, Schechter M. Oviedo-Joekes E, et al. Among authors: lajeunesse j. BMC Health Serv Res. 2023 May 26;23(1):553. doi: 10.1186/s12913-023-09558-6. BMC Health Serv Res. 2023. PMID: 37237256 Free PMC article.
The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic review.
Adams A, Blawatt S, Magel T, MacDonald S, Lajeunesse J, Harrison S, Byres D, Schechter MT, Oviedo-Joekes E. Adams A, et al. Among authors: lajeunesse j. Subst Abuse Treat Prev Policy. 2023 Sep 30;18(1):56. doi: 10.1186/s13011-023-00564-9. Subst Abuse Treat Prev Policy. 2023. PMID: 37777766 Free PMC article. Review.
The Impact of Injectable Opioid Agonist Treatment (iOAT) on Involvement in Criminalized Activities: A Secondary Analysis from a Clinical Trial in Vancouver, BC.
Dobischok S, Guh D, Marchand K, MacDonald S, Lock K, Harrison S, Lajeunesse J, Schechter MT, Oviedo-Joekes E. Dobischok S, et al. Among authors: lajeunesse j. Subst Abuse Rehabil. 2023 Nov 15;14:147-156. doi: 10.2147/SAR.S438451. eCollection 2023. Subst Abuse Rehabil. 2023. PMID: 38026787 Free PMC article.
[Medical escape games: experimenting with a new teaching method].
Larouche P, Sweeney K, Lajeunesse J. Larouche P, et al. Among authors: lajeunesse j. Can Med Educ J. 2024 Feb 29;15(1):78-79. doi: 10.36834/cmej.77290. eCollection 2024 Feb. Can Med Educ J. 2024. PMID: 38528889 Free PMC article. French.
Correction to: Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study.
Labeau SO, Afonso E, Benbenishty J, Blackwood B, Boulanger C, Brett SJ, Calvino-Gunther S, Chaboyer W, Coyer F, Deschepper M, François G, Honore PM, Jankovic R, Khanna AK, Llaurado-Serra M, Lin F, Rose L, Rubulotta F, Saager L, Williams G, Blot SI; DecubICUs Study Team; European Society of Intensive Care Medicine (ESICM) Trials Group Collaborators. Labeau SO, et al. Intensive Care Med. 2021 Apr;47(4):503-520. doi: 10.1007/s00134-020-06327-5. Intensive Care Med. 2021. PMID: 33635356 Free PMC article. No abstract available.
Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study.
Labeau SO, Afonso E, Benbenishty J, Blackwood B, Boulanger C, Brett SJ, Calvino-Gunther S, Chaboyer W, Coyer F, Deschepper M, François G, Honore PM, Jankovic R, Khanna AK, Llaurado-Serra M, Lin F, Rose L, Rubulotta F, Saager L, Williams G, Blot SI; DecubICUs Study Team; European Society of Intensive Care Medicine (ESICM) Trials Group Collaborators. Labeau SO, et al. Intensive Care Med. 2021 Feb;47(2):160-169. doi: 10.1007/s00134-020-06234-9. Epub 2020 Oct 9. Intensive Care Med. 2021. PMID: 33034686 Free PMC article.
20 results